Latest filing published 14 Mar 2022 for iTeos Therapeutics, Inc., €14k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joanne Jenkins Lager: trading record in brief
This profile gathers the share dealings of Joanne Jenkins Lager in iTeos Therapeutics, Inc., where the filings describe the role as senior executive. In total, 16 filings cover trades dated from 18 November 2021 to 11 March 2022.
The open-market record consists of 9 sales worth €1.9M, with no purchase. Besides market trades, the filings include 7 option exercises. In 2022 alone, the filings show no purchases and 6 sales.
The newest entry dates from 14 March 2022: an open-market sale of €114k, in iTeos Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joanne Jenkins Lager
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ US$4.306.4% of flowCommon StockSEC:0001209191-22-018669:0
- 3,500 shares@ US$4.306.2% of flowCommon StockSEC:0001209191-22-009568:0
- 3,500 shares@ US$4.306.2% of flowCommon StockSEC:0001209191-22-003605:0
- 7,000 shares@ US$4.3012.4% of flowCommon StockSEC:0001209191-22-001340:0
- 7,000 shares@ US$4.3012.5% of flowCommon StockSEC:0001209191-21-070453:0
- 3,500 shares@ US$4.306.3% of flowCommon StockSEC:0001209191-21-069136:0
- 28,000 shares@ US$4.3050.0% of flowCommon StockSEC:0001209191-21-065977:0
7 of 7 declarations
